- The long-term impact of the COVID-19 pandemic remains unclear; ability to conduct clinical trials at the expected pace is a risk factor in the evolving pandemic; clinical studies may not prove to be successful; timelines for completion of clinical studies are to some extent dependent on external factors outside the control of the Group, including resource capacity at clinical trial sites, competition for patients, etc.; financial success requires obtaining marketing authorization and achieving an acceptable reimbursement price for its drugs; there can be no guarantee that the drugs will obtain the selling prices or reimbursement rates foreseen; rapid and substantial technological change; highly competitive industry sector with many large players; patent and intellectual property risks; regulatory and commercial risks; funding and liquidity risk; impact of geopolitical situation and associated impacts on financial market conditions.
BerGenBio ASA
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, BerGenBio ASA disclosed greenhouse gas emissions of 5.5K tCO2e/year. By scope: Scope 2: 5,64 tCO2e/year; Scope 3: 4.9K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
5.5K tCO2e/year
2022
📊 Emissions by Scope (2022)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 5,64 tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 4.9K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022 | 5.5K tCO2e/year |
| 2021 | 1.8K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Tracked energy consumption and corresponding emissions; total emissions in 2022 was 54,63 tons CO2e (2021: 17,54 tons CO2e).
🎯 Climate & Sustainability Targets
🔜 Short-term
- Integrate ESG into business strategy; implement a waste minimization plan; complete work to align business with the Norwegian Transparency Act.
🌱 ESG Focus Areas
GovernanceClinical trial conductBusiness ethicsEconomic performancePatient health and safetyResponsible sourcingDiversity and inclusionPay equality and wage levelTalent attraction and retentionSkills for the futureWellbeing of employeesOccupational safetyGreenhouse gas emissions (GHG)Climate ChangeProtection of human and labor rights